Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tristan Boyd

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Rheumatic Diseases Clinics of North America|October 18, 2015
Novel Treatment Concepts in Psoriatic ArthritisTristan Boyd, Arthur Kavanaugh
Clinical and Experimental Rheumatology|October 13, 2015
Trial design in psoriatic arthritis: what could be changed?Arthur Kavanaugh, Tristan Boyd
Clinical and Experimental Rheumatology|October 17, 2015
Interleukin-17 inhibition in psoriatic arthritisTristan Boyd, Arthur Kavanaugh
Expert Opinion on Biological Therapy|November 18, 2015
Novel approaches to biological therapy for psoriatic arthritisTristan Boyd, Arthur Kavanaugh
Seminars in Arthritis and Rheumatism|April 25, 2021
The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritisAndreea C Damian, Keith Colaco, Sherry Rohekar, et al.
Clinical and Experimental Rheumatology|January 9, 2019
Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritisRoxana Coras, Arthur Kavanaugh, Tristan Boyd, et al.
Rheumatology International|March 31, 2012
Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohortLauren Mussen, Tristan Boyd, Vivian Bykerk, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 21, 2019
Pro- and anti-inflammatory eicosanoids in psoriatic arthritisRoxana Coras, Arthur Kavanaugh, Tristan Boyd, et al.
The Journal of Rheumatology|February 3, 2015
Choosing wisely: the Canadian Rheumatology Association's list of 5 items physicians and patients should questionShirley L Chow, J Carter Thorne, Mary J Bell, et al.
United European Gastroenterology Journal|July 5, 2024
Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessmentsSherry Rohekar, Tristan Boyd, Robert G Lambert, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Rheumatic Diseases Clinics of North America|October 18, 2015
Novel Treatment Concepts in Psoriatic ArthritisTristan Boyd, Arthur Kavanaugh
Clinical and Experimental Rheumatology|October 13, 2015
Trial design in psoriatic arthritis: what could be changed?Arthur Kavanaugh, Tristan Boyd
Clinical and Experimental Rheumatology|October 17, 2015
Interleukin-17 inhibition in psoriatic arthritisTristan Boyd, Arthur Kavanaugh
Expert Opinion on Biological Therapy|November 18, 2015
Novel approaches to biological therapy for psoriatic arthritisTristan Boyd, Arthur Kavanaugh
Seminars in Arthritis and Rheumatism|April 25, 2021
The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritisAndreea C Damian, Keith Colaco, Sherry Rohekar, et al.
Clinical and Experimental Rheumatology|January 9, 2019
Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritisRoxana Coras, Arthur Kavanaugh, Tristan Boyd, et al.
Rheumatology International|March 31, 2012
Low prevalence of work disability in early inflammatory arthritis (EIA) and early rheumatoid arthritis at enrollment into a multi-site registry: results from the catch cohortLauren Mussen, Tristan Boyd, Vivian Bykerk, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 21, 2019
Pro- and anti-inflammatory eicosanoids in psoriatic arthritisRoxana Coras, Arthur Kavanaugh, Tristan Boyd, et al.
The Journal of Rheumatology|February 3, 2015
Choosing wisely: the Canadian Rheumatology Association's list of 5 items physicians and patients should questionShirley L Chow, J Carter Thorne, Mary J Bell, et al.
United European Gastroenterology Journal|July 5, 2024
Initiation of vedolizumab did not provoke new-onset spondylarthritis in patients with inflammatory bowel disease: A prospective 24-week study with imaging assessmentsSherry Rohekar, Tristan Boyd, Robert G Lambert, et al.
Pageof 2